The European Medicines Agency (EMA, for its acronym in English) has announced it will investigate the possible relationship between influenza vaccine supply during the last pandemic (Pandemrix) and several cases of narcolepsy detected mainly in Sweden and Finland. The review is done at the request of the European Commission.In a statement, the agency said that "although the cases have been found to coincide in time with the use of Pandemrix not currently known if the
vaccine has caused this disorder and
the NHN1 vaccine and narcolepsy" At present, there are a score of suspected cases in Finland, six in Sweden and six in France, according to the newspaper announced yesterday Gallo 'Le Figaro'.
"So far, the Finns [and Sweden] have been detected in your system registry an unusual increase of
cases of narcolepsy in children vaccinated against
influenza," he told Antoni Trilla, public health specialist at the Hospital Clínic Barcelona. "They have no evidence that there is a direct and also in the middle of occasions, some have dismissed this partnership," he adds.
Relationship between NHN1 vaccine and narcolepsy
However, at the request of the European Commission, the College has launched Pandemrix research, made by GlaxoSmithKline, which has been applied to more than 30 million EU citizens since September 2009. The agency has announced that it will consider the "need to take interim measures until the completion of the evaluation." For the moment, "the precautionary principle, the
NHN1 vaccine and narcolepsy[the Finns] have stopped vaccinating children for this product," Trilla said.Narcolepsy in a rare sleep disorder that causes the person to fall asleep suddenly and unavoidably. "It is a purpose [adverse] rarely described," the specialist Catalan. Unknown origin of this problem but it is believed that genetic and environmental factors work together.For its part, the British pharmaceutical "is collaborating with the European agency in the investigation," according to sources based in Spain. to the
NHN1 vaccine and narcolepsy "We have much experience in programs of mass
vaccination," explain to this medium.
NHN1 vaccine increse the cases of narcolepsy
In these situations, there is usually more to explore but most of the time it is just a coincidence in time. "The Committee for Medicinal Products for Human Use shall be responsible for assessing Pandemrix the
NHN1 vaccine and narcolepsy. "It will look carefully all available data to determine whether evidence exists to establish a causal relationship," the EMA concrete.
